IVZ
Invictus Energy Ltd
🇦🇺 ASX
⚡️ ENERGY
📈 HIGH PRICE GROWTH
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 40.77%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
39
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Invictus Energy Ltd. Engages in the exploration and appraisal of Cabora Bassa Project. The company is headquartered in Perth, Western Australia. The company went IPO on 2012-01-19. The firm is focused on energy resources in sub-Saharan Africa. Its asset portfolio consists of 360,000 hectares within the Cabora Bassa Basin in Zimbabwe, SG 4571 and EPOs 1848/49 contain the Mukuyu and multiple Basin Margin prospects. SG 4571 covers approximately 250,000 acres located in the prospective portion of the Cabora Bassa Basin in northern Zimbabwe. SG 4571 and EPOs 1848/49 contain the Mukuyu and multiple Basin Margin prospects. The Company’s subsidiaries include HIS Texas LLC, Invictus Energy Resources Pty Limited, Invictus Energy Mauritius Limited, Invictus Energy Resources Zimbabwe (Pvt) Ltd, Geo Associates (Pvt) Ltd, Miombo Forest Carbon Investments Pty Ltd, Miombo Forest Carbon Investments Mauritius Ltd, and Miombo Forest Carbon Investments Zimbabwe (Pvt) Ltd.
📈 Performance
Price History
-38.95%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.08
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in IVZ
39
📊 Total Capital Earnings
$65K
🔃 Average investment frequency
33 weeks
💵 Average investment amount
$2,465
⏰ Last time a customer invested in IVZ
19 days
IVZ investor breakdown
💵 Income of investors
More than 200k
150k - 200k
7%
100k - 150k
24%
50k - 100k
44%
Less than 50k
22%
👶 Age of investors
18 - 25
26 - 34
49%
35 - 90
46%
🙋 Legal gender of investors
Female
44%
Male
56%
Pearlers who invest in IVZ also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.03%
📊 Share price
$103.94 AUD
🇦🇺 AUSTRALIA
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
13.44%
📊 Share price
$142.53 AUD
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🌏 GLOBAL
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
19.55%
📊 Share price
$64.45 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
Pilbara Minerals Ltd. engages in the exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 917 full-time employees. The company went IPO on 2007-09-19. The firm is primarily engaged in the exploration, development, and mining of minerals in Australia. Its 100% owned Pilgangoora hard-rock lithium operation is located approximately 120 kilometers (kms) from Port Hedland in Western Australia’s resource-rich Pilbara region. The operation consists of two processing plants: the Pilgan Plant, located on the northern side of the Pilgangoora area and produces spodumene and tantalite concentrates, and the Ngungaju Plant is located to the south produces spodumene concentrate. The company owns 70% of the Mt Francisco project, which is located 50 km south-west of the Pilgangoora Project and hosts the large occurrence of outcropping pegmatites located nearby to Port Hedland. The company is also pursuing a proposed downstream joint venture (JV) for the development of an approximately 43,000 tons per annum (tpa) lithium carbonate equivalent (LCE) lithium chemical conversion facility in South Korea.
🙌 Performance (5Yr p.a)
115.39%
📊 Share price
$2.37 AUD
⛏️ MINING
Want more shares? Try these...
IWLD.AX was created on 2016-04-22 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global, developed market large, mid and smallcapitalisation companies
🙌 Performance (5Yr p.a)
11.49%
📊 Share price
$62.91 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
⛳️ DIVERSIFIED
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
19.55%
📊 Share price
$64.45 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
Invion Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-02-15. Invion Limited is an Australia-based life science company. The firm is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The firm is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. The company holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.
🙌 Performance (5Yr p.a)
330.00%
📊 Share price
$0.21 AUD
📦 LOGISTICS